Published in Infect Immun on February 01, 1977
Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev (1983) 3.76
Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol (1981) 2.50
Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines. Infect Immun (1981) 1.69
Role of antibody in Coxiella burnetii infection. Infect Immun (1981) 1.13
Appearance of cellular and humoral immunity in guinea pigs after infection with Coxiella burnetii administered in small-particle aerosols. Infect Immun (1977) 1.12
Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii. Infect Immun (2010) 1.11
Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation. Infect Immun (2002) 1.05
Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine. Infect Immun (1978) 1.04
Histologic, immunofluorescence, and electron microscopic study of infectious process in mouse lung after intranasal challenge with Coxiella burnetii. Infect Immun (1988) 1.01
Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent. BMC Immunol (2009) 0.94
Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia. Clin Exp Immunol (1980) 0.93
Host-parasite interaction and development of infraforms in chicken embryos infected with Coxiella burnetii via the yolk sac. Infect Immun (1981) 0.85
Formalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG. Infect Immun (2013) 0.81
DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS. J Immunol (1964) 14.77
Alterations of macrophage functions by mediators from lymphocytes. J Exp Med (1971) 7.95
Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun (1970) 5.96
Phase variation of the Nine Mile and other strains of Rickettsia burneti. Can J Microbiol (1956) 5.73
Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity. J Exp Med (1971) 4.94
The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J Exp Med (1973) 4.51
The mediator of cellular immunity. IV. Cooperation between lymphocytes and mononuclear phagocytes. Cell Immunol (1971) 2.34
Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity. J Immunol (1973) 2.08
Migration inhibitory factor associated with delayed-type hypersensitivity. Fed Proc (1990) 2.02
Electron microscopic study on the interaction between normal guinea pig peritoneal macrophages and Coxiella burnetii. Infect Immun (1976) 1.65
Detection of long-term cellular immunity to Coxiella burneti as assayed by lymphocyte transformation. Infect Immun (1975) 1.55
In vitro assessment of cellular immunity to vaccinia virus: contribution of lymphocytes and macrophages. Infect Immun (1970) 1.46
Interaction between Coxiella burnetii and guinea pig peritoneal macrophages. Infect Immun (1976) 1.40
Phagocytosis of Coxiella burneti by macrophages. Acta Virol (1975) 1.25
Phagocytosis of coxiella burneti, phase I and phase II by peritoneal monocytes from normal and immune guinea pigs and mice. Zentralbl Bakteriol Orig (1968) 1.24
Specific macrophage immunity to vaccinia virus: macrophage-virus interaction. Infect Immun (1972) 1.19
STUDY OF THE ANTIGENIC STRUCTURE OF COXIELLA BURNETI. IV. PHAGOCYTOSIS AND OPSONIZATION IN RELATION TO THE PHASES OF C. BURNETI. Acta Virol (1965) 1.16
The cellular immune response to antigens of Coxiella burneti. Can J Microbiol (1974) 1.11
Interaction of rickettsiae and phagocytic host cells. V. Phagocytic and opsonic interactions of phase 1 and phase 2 Coxiella burneti with normal and immune human leukocytes and antibodies. J Immunol (1967) 1.07
Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits. Infect Immun (1974) 0.95
Characterization of monkey peripheral neutrophil granules during infection. Infect Immun (1975) 0.82
Isolation and characterization of a native cell wall complex from Neisseria meningitidis. Infect Immun (1972) 2.43
In vitro interaction between normal cynolmolgus monkey alveolar macrophages and Legionnaires disease bacteria. Infect Immun (1979) 1.93
Urinary ascariasis in a man with hematuria. South Med J (2001) 1.92
Neurological and physiological responses of the primate to anthrax toxin. J Infect Dis (1968) 1.88
Influenza alone and in sequence with pneumonia due to Streptococcus pneumoniae in the squirrel monkey. J Infect Dis (1975) 1.88
A year's experience of functional budgeting in a clinical department. Anaesthesia (1981) 1.72
Electron microscopic study on the interaction between normal guinea pig peritoneal macrophages and Coxiella burnetii. Infect Immun (1976) 1.65
In vitro responses of guinea pig peritoneal macrophages to Legionella pneumophila. Infect Immun (1981) 1.64
Small-particle aerosols of antiviral compounds in treatment of type A influenza pneumonia in mice. J Infect Dis (1976) 1.56
Analytical fractionation of mouse peritoneal macrophages: physical and biochemical properties of subcellular organelles from resident (unstimulated) and cultivated cells. J Reticuloendothel Soc (1978) 1.56
Therapeutic effects of ribavirin given by the intraperitoneal or aerosol route against influenza virus infections in mice. Antimicrob Agents Chemother (1976) 1.55
Clinical and clinicopathologic findings in tropical canine pancytopenia. J Am Vet Med Assoc (1970) 1.54
Role of the lymphatics in the pathogenesis of anthrax. J Infect Dis (1965) 1.52
Pathophysiology of anthrax. J Infect Dis (1966) 1.52
Value of field data for extrapolation in anthrax. Fed Proc (1967) 1.48
Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes. Infect Immun (1975) 1.46
Lysosomes in skeletal muscle tissue. Zonal centrifugation evidence for multiple cellular sources. J Cell Biol (1970) 1.44
Tropical canine pancytopenia. J Am Vet Med Assoc (1970) 1.43
Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin. Antimicrob Agents Chemother (1975) 1.43
Cost of anaesthesia. Br Med J (Clin Res Ed) (1982) 1.40
Interaction between Coxiella burnetii and guinea pig peritoneal macrophages. Infect Immun (1976) 1.40
Purification of large quantities of coxiella burnetii rickettsia by density gradient zonal centrifugation. Appl Microbiol (1972) 1.39
In vitro guinea pig leukocyte reactions to Rickettsia rickettsii. Infect Immun (1977) 1.38
Treatment of influenza infection of mice by using rimantadine hydrochlorides by the aerosol and intraperitoneal routes. Antimicrob Agents Chemother (1975) 1.34
Experimental Q fever infection in congenitally athymic nude mice. Infect Immun (1978) 1.34
Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. Antimicrob Agents Chemother (1983) 1.33
Pathophysiological changes in the rat associated with anthrax toxin. J Infect Dis (1968) 1.30
Pathogenesis of respiratory Klebsiella pneumoniae infection in rats: bacteriological and histological findings and metabolic alterations. Infect Immun (1977) 1.29
Serological relation between Rift Valley fever virus and viruses of phlebotomus fever serogroup. Lancet (1980) 1.29
Electron spin resonance studies of spin-labeled mammalian cells by detection of surface-membrane signals. Proc Natl Acad Sci U S A (1973) 1.27
Cost of anaesthetic drugs and clinical budgeting. Br Med J (Clin Res Ed) (1986) 1.26
Human leucocyte antigens in Crohn's disease and ulcerative colitis. Gut (1972) 1.26
A precise method for replicating suspension cultures of mammalian cells. Appl Microbiol (1968) 1.23
Continuous aerosol therapy system using a modified Collison nebulizer. J Clin Microbiol (1977) 1.23
Lymphocyte reactivity in pregnancy. Br Med J (1972) 1.21
Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters. Infect Immun (1977) 1.18
Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. Am J Vet Res (1987) 1.15
Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus. Vet Rec (1981) 1.13
Appearance of cellular and humoral immunity in guinea pigs after infection with Coxiella burnetii administered in small-particle aerosols. Infect Immun (1977) 1.12
Carbohydrate repression of catalase synthesis in Bacteroides fragilis. J Bacteriol (1977) 1.11
Immune response of steers, goats and sheep to inactivated Rift Valley Fever vaccine. Proc Annu Meet U S Anim Health Assoc (1979) 1.11
Effects of ribavirin on red blood cells. Toxicol Appl Pharmacol (1984) 1.09
Pathology of canine ehrlichiosis (tropical canine pancytopenia). Am J Vet Res (1973) 1.08
In vivo growth and distribution of anthrax bacilli in resistant, susceptible, and immunized hosts. J Bacteriol (1967) 1.07
Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. Antiviral Res (1987) 1.06
Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin Pharmacol Ther (1992) 1.05
Temporal appearance of opsonizing antibody to Francisella tularensis: detection by a radiometabolic assay. Infect Immun (1975) 1.05
Involvement of small mammals in the transmission of scrub typhus in Malaysia: isolation and serological evidence. Trans R Soc Trop Med Hyg (1973) 1.05
Pathophysiological and biochemical changes in anthrax. Fed Proc (1967) 1.05
Response of influenza virus-infected mice to selected doses of ribavirin administered intraperitoneally or by aerosol. Antimicrob Agents Chemother (1977) 1.05
Attempts to infect and demonstrate transovarial transmission of R. tsutsugamushi in three species of Leptotrombidium mites. Ann N Y Acad Sci (1975) 1.05
Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine. Infect Immun (1978) 1.04
Pathogenesis of tularemia in immune and nonimmune rats. Am J Vet Res (1975) 1.04
Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice. Antimicrob Agents Chemother (1985) 1.04
Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin Exp Immunol (2001) 1.02
Relationship of serum beta-glucuronidase and lysozyme to pathogenesis of tularemia in immune and nonimmune rats. Infect Immun (1975) 1.01
Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides. J Med Chem (1984) 1.01
Hantaan virus, aetiological agent of Korean haemorrhagic fever, has Bunyaviridae-like morphology. Lancet (1982) 1.00
Immunoglobulin-bearing cells in lungs of mice infected with influenza virus. Infect Immun (1976) 1.00
Aerosol therapy of influenza infections of mice and primates with rimantadine, ribavirin, and related compounds. Ann N Y Acad Sci (1977) 1.00
Aerosol evaluations of the DeVilbiss No. 40 and Vaponefrin nebulizers. Appl Environ Microbiol (1976) 1.00
Hematological and bone marrow effects of ribavirin in rhesus monkeys. Toxicol Appl Pharmacol (1984) 1.00
Induced metabolic sequelae of tularemia in the rat: correlation with tissue damage. Am J Physiol (1975) 0.99
Cynomolgus monkey model for experimental Q fever infection. J Infect Dis (1979) 0.98
Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. Antimicrob Agents Chemother (1984) 0.98
Recovery of alveolar macrophages from rhesus and cynomolgus macaques by lung lavage. Am J Vet Res (1979) 0.97
Neurological and physiological responses of the primate to anthrax infection. J Infect Dis (1968) 0.97
Melioidosis: serologic studies on US Army personnel returning from Southeast Asia. Mil Med (1971) 0.96
Prophylactic oral antibiotics for low-risk dog bite wounds. Pediatr Emerg Care (1992) 0.96
In-vivo activity of antivirals against exotic RNA viral infections. J Antimicrob Chemother (1984) 0.95
Filter paper collection of blood for use in a screening and diagnostic test for scrub typhus using the IFAT. Trans R Soc Trop Med Hyg (1972) 0.94
The use of acridine orange as a lysosomal marker in rat skeletal muscle. J Cell Biol (1969) 0.94
Hyperalgesia due to nerve damage: role of nerve growth factor. Pain (1999) 0.94
Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia. Clin Exp Immunol (1980) 0.93
Antibody response to Rocky Mountain spotted fever. J Clin Microbiol (1976) 0.93
Effects of nitric oxide synthase inhibition on ciliary blood flow, aqueous production and intraocular pressure. Exp Eye Res (2001) 0.93
Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs. Antimicrob Agents Chemother (1986) 0.92
The effect of habitat on the prevalence of human scrub typhus in Malaysia. Trans R Soc Trop Med Hyg (1972) 0.90
Efficacy, toxicology and clinical applications of ribavirin against virulent RNA viral infections. Antiviral Res (1985) 0.90
Immunological studies in acute myeloid leukaemia: PHA responsiveness and serum inhibitory factors. Br J Cancer (1973) 0.90
Therapeutic effects of small-particle aerosols of ribavirin on parainfluenza (sendai) virus infections of mice. Antimicrob Agents Chemother (1976) 0.90
Exposure of guinea pigs to Rickettsia rickettsii by aerosol, nasal, conjunctival, gastric, and subcutaneous routes and protection afforded by an experimental vaccine. Infect Immun (1979) 0.89
Factors affecting production of catalase by Bacteroides. J Clin Microbiol (1978) 0.88
The use of acid alumina and sephadex LH-20 for the separation and characterization of ethanol-soluble peptides produced by Bacillus brevis. Biochem J (1972) 0.86
Development of hypergammaglobulinemia in tropical canine pancytopenia. Am J Vet Res (1971) 0.86
Ehrlichia canis--the causative agent of a haemorrhagic disease of dogs? Vet Rec (1969) 0.86
Experimental Coxiella burnetii infection of guinea pigs and mice. Lab Anim Sci (1978) 0.86
Evaluation of factors related to growth of Rift Valley fever virus in suspended cell cultures. Appl Microbiol (1969) 0.86
Effect of temperature and drug therapy on anthrax intoxication. Proc Soc Exp Biol Med (1967) 0.86
Q fever: diagnosis, therapy, and immunoprophylaxis. Mil Med (1979) 0.85
Mammals and scrub typhus ecology in peninsular Malaysia. Trans R Soc Trop Med Hyg (1975) 0.85
Aerosol Q fever infection of the nude mouse. Vet Pathol (1981) 0.85
Rectal blowout by personal watercraft water jet: case report and review of literature. J Trauma (1999) 0.85